Market Trends of Tissue Microarray Industry
Immunohistochemistry Segment is Expected to Hold a Significant Market Share in the Tissue Microarray Market
- Immunohistochemistry is one of the most common applications of immunostaining. It involves the process of selectively identifying antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.
- The major factors fueling segment growth are the increasing application of immunohistochemistry in tissue diagnostics and the growing research and development. For instance, as per the study published in February 2022 in Scientific Reports, a novel detection technique for activated Rac/Cdc42 in human cancer FFPE tissues was developed by scientists using a developed rapid immunohistochemistry (R-IHC) device. The device helps in carrying out antigen-antibody reactions that can be facilitated up to 1,200-fold by alternating current-based high-speed micro agitation. Such advantages of microarrays in immunohistochemistry research are expected to drive market growth due to increased adoption.
- Additionally, the launch of new products is also propelling the market's growth due to the increased adoption of biotechnological research. For instance, in March 2021, Roche launched the DISCOVERY Green HRP kit. It is the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell populations in tissue-based research. The DISCOVERY Green HRP (horseradish peroxidase) kit can be used in combination with other detection kits, expanding the multiplexing capability of both immunohistochemistry (IHC) and in situ hybridization (ISH) by providing a distinct color that contrasts with other chromogens.
- Thus, due to the rising initiatives from the key market players and increasing applications of immunohistochemistry, the market is expected to witness significant growth over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
- In North America, the United States has held a major share of the market. The major factors contributing to the market growth are the presence of many market players engaged in manufacturing and expanding the portfolio of instruments and reagents for molecular diagnostic testing. The region also witnesses the presence of well-established healthcare diagnostic facilities.
- According to the American Cancer Society 2023, 1.9 million new cancer cases are expected to be diagnosed in the United States in 2023. Furthermore, according to the Government of Canada, in June 2022, an estimated 233,900 people in Canada will be diagnosed with cancer 2022. Such a huge incidence of cancers in North America is therefore expected to drive market growth in this region due to the increased adoption of tissue microarray for cancer research in the region.
- Strategic initiatives adopted by the key market players are anticipated to drive market growth. For instance, in January 2022, Histobiolab, a division of Creative Bioarray, reported that it had developed a professional tissue microarray to meet precise research needs. In addition, in July 2021, BioIVT acquired Tissue Solutions Ltd, a provider of high-quality human tissue and other biological materials for use in drug discovery, target identification and validation, assay development and validation, and biomarker and companion diagnostic development. Such launches and partnerships in the region helps in reaching out to a large client base, driving the market growth.
- Thus, the factors such as rising incidence of cancers and initiatives adopted by the key market players are expected to witness significant growth over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
